Wendy B. Young - 07 Nov 2024 Form 3 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
RAPP
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
3
Filing time
07 Nov 2024, 18:27:36 UTC
Next filing
13 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RAPP Stock Option (Right to Buy) 07 Nov 2024 Common Stock 2,335 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vested and became exercisable on September 28, 2024, and the remaining shares will vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney